EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research progress on potential high-risk drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis with insights from adverse drug reaction database mining

Houci Yang, Junjun Xu, Jiali Zhang, Xiaoyu Zhang, Chenghui Jin, Haibin Dai, Mingdong Yang

Frontiers in Pharmacology · 02.06.2026 · 17

DOI: 10.3389/fphar.2026.1775888 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.06.2026. Verfasst von Houci Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare yet life-threatening severe cutaneous adverse drug reactions (SCARs), characterized by high mortality and substantial morbidity risks. Identifying potential high-risk drugs associated with SJS/TEN is crucial for guiding clinical preventive interventions, enabling early detection, and enhancing risk management. With the rapid advancement of data science, adverse drug reaction (ADR) database mining has emerged as a powerful tool for systematically investigating the drug-SJS/TEN association, effectively overcoming the limitations of traditional case reports and small-sample studies regarding data scale and conclusion generalizability. This review summarizes recent advances in identifying potential high-risk drugs for SJS/TEN based on ADR database mining, with all included studies retrieved from peer-reviewed journals and strictly focused on SJS/TEN. We classify and discuss the major potential high-risk drug categories, including antibiotics, antiepileptics, allopurinol, nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs), immune checkpoint inhibitors (ICIs), novel antiandrogens, carbonic anhydrase inhibitors, antivirals, and others. We also summarize their associated genetic susceptibilities, median onset times, and underlying mechanisms. These findings provide valuable references for enhancing medication safety and mitigating severe adverse drug reactions in clinical practice.

Schlagwörter

Stichwörter der Autor:innen

Stevens-Johnson syndrome (SJS)adverse drug reaction (ADR)data miningpharmacovigilancethe FDA adverse event reporting system (FAERS)time to onset (TTO)toxic epidermal necrolysis (TEN)

Autor:innen und Institutionen

  • Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Zitieren

APA

Yang, H., Xu, J., Zhang, J., Zhang, X., Jin, C., Dai, H., & Yang, M. (2026). Research progress on potential high-risk drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis with insights from adverse drug reaction database mining. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1775888

Vancouver

Yang H, Xu J, Zhang J, Zhang X, Jin C, Dai H, et al. Research progress on potential high-risk drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis with insights from adverse drug reaction database mining. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1775888

BibTeX
@article{Yang2026,
  author = {Yang, Houci and Xu, Junjun and Zhang, Jiali and Zhang, Xiaoyu and Jin, Chenghui and Dai, Haibin and Yang, Mingdong},
  title = {Research progress on potential high-risk drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis with insights from adverse drug reaction database mining},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1775888}
}
Kostenlos starten →